Research Article
Clinical Characteristics and Microorganisms Isolated in Community-Acquired Pneumonia in the COVID-19 Period
Table 4
Differences between patients with hospital mortality and patients alive at discharge.
| | | Deceased (n = 28) | Alive (n = 197) | value |
| | Age, years [median (percentiles 25–75)] | 80 (72–89) | 73 (61–85) | 0.009 | | Sex (male) | 17 (61%) | 115 (58%) | 0.814 | | HBP, n (%) | 18 (64%) | 117 (59%) | 0.621 | | DM, n (%) | 8 (29%) | 50 (25%) | 0.718 | | COPD, n (%) | 8 (29%) | 49 (25%) | 0.674 | | Asma, n (%) | 2 (7%) | 13 (7%) | 1 | | Chronic heart disease, n (%) | 8 (29%) | 60 (31%) | 0.839 | | Chronic renal disease, n (%) | 4 (14%) | 34 (17%) | 1 | | Chronic neurological disease, n (%) | 12 (43%) | 47 (24%) | 0.032 | | Chronic hepatic disease, n (%) | 1 (4%) | 16 (8%) | 0.702 | | Active oncohematological disease, n (%) | 6 (21%) | 15 (8%) | 0.031 | | Immunocompromised patients, n (%) | 4 (14%) | 15 (8%) | 0.513 | | HIV, n (%) | 1 (4%) | 5 (2.5%) | 0.554 | | Charlson score [median (percentiles 25–75)] | 6 (4–8) | 5 (3–6) | 0.036 | | Leucocytes (×103) [median (percentiles 25–75)] | 13.5 (10.3–20.2) | 13.3 (9.2–17) | 0.385 | | PCR (n = 220) [median (percentiles 25–75)] | 16.5 (3.5–24.9) | 10.7 (4.5–22.2) | 0.543 | | PCT (n = 70) [median (percentiles 25–75)] | 2.3 (0.16–5.43) | 0.31 (0.1–1.21) | 0.101 | | NEWS2 score [median (percentiles 25–75)] | 7 (4–9) | 4 (2–6) | 0.001 | | Antibiotic duration (days) | 7 (4–11) | 10 (7–12) | 0.004 | | Admission duration (days) | 7 (3–16) | 7 (5–12) | 0.861 | | Bronchoaspiration, n (%) | 13 (47%) | 31 (16%) | 0.000 | | ICU, n (%) | 3 (11%) | 11 (6%) | 0.392 | | Intubation, n (%) | 3 (11%) | 8 (4%) | 0.144 | | Intubation duration (days), n (%) | 5 (2–7) | 4 (2–9) | 0.667 | | High flow oxygen, n (%) | 3 (11%) | 4 (2%) | 0.043 | | High flow oxygen duration (days) | 3 (1–8) | 1 (1–5) | 0.7 | | Transfer to sociosanitary facility, n (%) | 1 (4%) | 22 (11%) | 0.324 |
|
|
The bold values indicate that statistical significance was set at p < 0.05.
|
